Gene III(R) Ergothioneine, alone or combined with vitamin K2, vitamin D3 and magnesium L-threonate, attenuates bone turnover, inflammatory and oxidative disturbances in ovariectomized mice
W.T. LiuiD, Y Tanye Tang, Wei Ding, Juan Cao, Cong Guo, Guohua XiaoiD
Abstract
PurposeEstrogen deficiency drives bone loss through a complex interplay of endocrine, oxidative, inflammatory, and bone-remodeling disturbances. Ergothioneine (EGT) is a diet-derived thiol/thione antioxidant, yet its effects on the estrogen-deficient skeleton remain unknown. This study evaluated whether EGT-alone or combined with vitamin K2, vitamin D3, and magnesium L-threonate-attenuates the skeletal and systemic consequences of ovariectomy (OVX) in mice. MethodsForty-eight female C57BL/6J mice underwent either sham surgery or OVX. For 12 weeks, the mice received a daily oral gavage of one of the following: vehicle, alendronate (1.53 mg/kg), EGT (30 mg/kg/day), EGT with vitamin K2 (40 {micro}g/kg/day) and vitamin D3 (500 IU/kg/day), or EGT with vitamin K2, magnesium L-threonate (350 mg/kg/day), and vitamin D3 (n = 5-6 per group). Outcomes evaluated included the uterine index, tibial micro-computed tomography (micro-CT), distal-femoral histology, serum bone turnover markers (CTX-I, PINP, osteocalcin), sex hormones, TNF-, IL-6, SOD, and MDA. ResultsOVX significantly lowered the uterine index and induced tibial trabecular deterioration. This was accompanied by increased CTX-I, TNF-, IL-6, and MDA, alongside decreased PINP, osteocalcin, and SOD (all P 0.05 vs. OVX), they significantly increased the trabecular area in distal-femoral histology (14.2-15.0% across regimens vs. 7.6% in OVX; P < 0.05). Furthermore, EGT treatments lowered CTX-I, TNF-, IL-6, and MDA, increased SOD, and partially restored PINP and osteocalcin (P < 0.05-0.01 vs. OVX). Apparent increases in serum estradiol were assay-dependent and are considered exploratory. ConclusionEGT-based nutritional regimens improved the systemic oxidative, inflammatory, and bone-turnover environments associated with estrogen-deficient bone loss and successfully preserved the distal-femoral trabecular area. However, tibial three-dimensional microarchitecture was not restored on micro-CT. Given that histological and micro-CT endpoints were evaluated at different skeletal sites, structural interpretations should be made with caution. These findings support the further evaluation of EGT as a dietary adjunct, warranting subsequent mechanistic and dose-optimization studies.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Tributyltin Protects Against Ovariectomy-Induced Trabecular Bone Loss in C57BL/6J Mice with an Attenuated Effect in High Fat Fed Mice
R. Freid, A. Hussein, J. Schlezinger·bioRxiv·Apr 28, 2021
- The Role of Osteocyte Estrogen Receptor β in Bone Mass Maintenance and Tibial Stiffness Following Sex Hormone Withdrawal in Male and Female Mice
Xiaoyu Xu, Michell Hoge, … Russell P. Main·bioRxiv·Jun 3, 2026
- Mmp-13 deletion in cells of the mesenchymal lineage increases bone mass, decreases endocortical osteoclast number, and attenuates the cortical bone loss caused by estrogen deficiency in mice
Filipa Ponte, Ha‐Neui Kim, … Stavros C. Manolagas·bioRxiv·Jul 15, 2021
- Estrogens protect bone mass by inhibiting NAD+ metabolism in osteoclasts
Adriana Marques-Carvalho, Gareeballah Osman Adam, … Maria Almeida·bioRxiv·Jul 11, 2025
- Estrogen Signaling in Arcuate Kiss1 Neurons Suppresses a Sex-Dependent Circuit That Promotes Dense Strong Bones in Female Mice
C. B. Herber, W. C. Krause, … H. A. Ingraham·bioRxiv·May 21, 2018
- The effect of estradiol during the early stages of osteoclast differentiation is associated with the accumulation of phosphorylated p53 in mitochondria and the inhibition of mitochondrial metabolism.
A. M. Carvalho, B. Silva, … V. A. Sardao·bioRxiv·Mar 30, 2023